At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians, nurses and researchers are committed to streamlining the process of translating discoveries into treatments and cures.
The Office of Technology Transfer is committed to this vision. It is our mission to maximize the impact of institutional innovations and research excellence by facilitating the translation and commercialization of scientific discoveries into accessible healthcare products and services that benefit patients worldwide.
Novel Medical Technology for Craniomaxillofacial Surgery Receives FDA Clearance for Market
Houston Methodist recently reached a major milestone, receiving U.S. Food and Drug Administration (FDA) 510(k) clearance to market the AnatomicAligner, a novel, comprehensive software program used to improve planning for craniomaxillofacial (CMF) surgeries. Learn More >
Revolutionary Stroke Recovery Through Cap-based Therapy Developed At Methodist
The electromagnetic cap, using TRPMS and a smart phone app to stimulate precise points in the brain, provides stroke patients with an affordable and portable home-based therapy. Learn More >
A Leader In Covid-19 Research and Innovation
The new coronavirus disease 2019 (COVID-19) outbreak is a rapidly evolving situation, the Academic Institute is dedicated to coordinating clinical trials, developing new vaccines and treatment, and producing PPE, ventilators, and critical medical technologies. Learn More.
Houston Methodist Attends Bio Digital 2020
The Office of Technology Transfer team will be representing Houston Methodist at the annual BIO International Convention on June 8-12, 2020. Learn More.
WE ARE LOCATED IN THE HEART OF THE TEXAS MEDICAL CENTER AND PROUDLY SERVE ALL THE HOSPITALS AND ENTITIES IN THE HOUSTON METHODIST HOSPITAL SYSTEM